Grant awarded for non-antibiotic solution to drug resistant bacteria
research project
that aims to eliminate
drug-resistant bacteria
without antibiotics has received a grant of Rs 62 lakh from the Gujarat govt.
The study, initiated by Dr Dhara Patel, dean of the Faculty of Medical Sciences at Charusat University in Changa, aims to directly target
pan-drug resistant bacteria
, one of the greatest global health threats.
Tired of too many ads? go ad free now
Patel's study is set to run for three years. Her co-investigator is Dr Sishir Gang, chairman of the nephrology department at Muljibhai Patel Urological Hospital in Nadiad.
The World Health Organization's projections state that antibiotics could become obsolete by 2050, making even minor infections potentially fatal. The emergence of pan-drug resistant bacteria — microbes that resist all known antibiotics — has accelerated the urgency for
alternative treatment strategies
.
"Our goal is to identify molecular pathways — what we are calling 'kill switches' — within these resistant bacteria," said Patel. "If we can understand how to trigger these internal mechanisms, we may be able to force the bacteria to shut down or self-destruct, much like activating an internal alarm system. This approach could provide a powerful alternative to traditional antibiotics."
The focus of the study in dialysis patients, in whom bacterial infections often compromise tunnelled cuffed catheters — a vital lifeline for kidney failure patients.
These catheters frequently fail due to colonization by drug-resistant bacteria, forcing painful, costly and dangerous replacement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
22 minutes ago
- Business Standard
Dev IT secures Rs 4-cr orders from Alivus Lifesciences
Dev Information Technology (DEV IT) announced that it has secured orders worth Rs 4.4 crore from Alivus Lifesciences. Shares of Alivus Lifesciences rose 0.50% to Rs 1,038.30 on the BSE. According to an exchange filing, the engagement includes a major order worth Rs 3.60 crore for Microsoft Select Plus perpetual licenses. While the licenses will be billed directly by the Licensing Solution Partner, DEVIT played a key advisory role in aligning Alivus Lifesciences IT infrastructure with the appropriate Microsoft licensing model. This highlights DEVITs capability in managing complex enterprise IT requirements and supporting clients in their digital transformation initiatives. In addition, DEVIT secured a direct order worth Rs 80 lakh from Alivus Lifesciences for a suite of enterprise software solutions. This includes products from Microsoft, Zoho, Adobe, and TeamViewer, underscoring the companys ability to deliver integrated, multi-product IT solutions tailored to specific business needs. Dev Information Technology (DEV IT) is a technology solution provider helping companies in their digital transformation from advisory to execution, backed by expert applications and infrastructure management. Alivus Life Sciences Limited (Formerly Glenmark Life Sciences is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes. Shares of Dev Information Technology shed 0.33% to Rs 121.40 on the BSE.
New Indian Express
28 minutes ago
- New Indian Express
Infosys Foundation funds free maternal, child healthcare
BENGALURU: Infosys Foundation, the CSR arm of Infosys, on Wednesday announced a partnership with Prashanthi Balamandira Trust, an organisation that provides education, healthcare, nutrition, and community service free of charge in Karnataka, to support free medical services for women and children in rural Karnataka. The foundation will provide a grant of over Rs 48 crore to Sri Sathya Sai Sarla Memorial Hospital in Chikkaballapur, which functions under the Sri Madhusudan Sai Institute of Medical Sciences and Research (SMSIMSR). The funds will be used to improve healthcare facilities, especially in areas related to maternal and child care. The hospital will offer services such as maternity care, pediatric treatment, gynaecological procedures, and heart-related interventions and surgeries for children. All services will be provided free of cost. Sri Madhusudan Sai, founder of SMSIMSR and trustee of the Prashanthi Balamandira Trust, said the support from Infosys Foundation will help improve services for women and children, who otherwise struggle to access quality healthcare. He added that the hospital, as a teaching institution, will use the new facilities to train medical and nursing students. Infosys Foundation trustee Sunil Kumar Dhareshwar said the aim is to make essential healthcare available to people who cannot afford it.
New Indian Express
28 minutes ago
- New Indian Express
Family of Sigachi blast victim alleges high hospital bill for relative's treatment
SANGAREDDY: Amidst the scenes of grief following the tragedy, it's business as usual for hospitals. Munmun Chowhan, a worker from Madhya Pradesh employed at the Sigachi factory, sustained critical burn injuries in the blast and was admitted to Dhruva Hospital in Patancheru for treatment. On learning of Chowhan's condition, his father-in-law, Birender Chowdhary, travelled to see him. However, upon seeing his severely injured son-in-law, Birender Chowdhary developed high blood pressure and fell ill. He was admitted to the same hospital. The family expressed concern over the hospital bill for Birender Chowdhary's treatment. The hospital reportedly charged them Rs 1 lakh for one night. 'So far we have paid Rs 70,000. We do not know how we will pay the remaining amount,' said Sonu Chowdhary, Birender's son. Meanwhile Dhruva Hospital manager A Pramod told TNIE that there was no truth in the claim, saying that Chowdhary was billed Rs 40,000 for the overnight stay and another Rs 15,000 for medicines.
